Base excision repair (BER) protects against damage to DNA from reactive oxygen species, methylation, deamination, hydroxylation and other byproducts of cellular metabolism. Until last year, inherited deficiencies in the BER pathway had not been causally linked with any human genetic disorder.
The base excision repair pathway
The base excision repair (BER) pathway plays a significant role in the repair of mutations caused by reactive oxygen species (ROS) that are generated during aerobic metabolism (1) . BER is a multi-step process that involves the sequential activity of several proteins. DNA glycosylases initiate this repair pathway by recognising and removing a damaged or improper base by hydrolysing the N-glycosidic bond. To date, ten DNA glycosylases have been characterised and cloned in humans, and each excises an overlapping subset of oxidised, deaminated, alkylated, or mismatched bases (2) . To complete the repair process, the apurinic/apyrimidinic (AP) site is further processed by an incision step, DNA synthesis, an excision step, and DNA ligation through either the short or long-patch BER pathways. Despite the critical nature of these functions, knockout mouse models of individual glycosylases appeared to be phenotypically normal. Partial redundancy between glycosylases and an overlap with transcription coupled repair was proposed as a likely explanation (3) . Furthermore, although inherited deficiencies involving components of the nucleotide excision repair, mismatch repair and recombinational repair pathway had all been linked to specific human genetic disorders, no inherited disorder of BER had been identified (3) .
Established colorectal cancer genes
Inherited factors are thought to play a major role in at least 15% of colorectal cancers (CRC), but established CRC predisposition genes account for only a minority of these (4) . Familial adenomatous polyposis (FAP) (MIM 175100) is an autosomal dominant disorder associated with the development of hundreds or thousands of colorectal adenomas, some of which progress to cancer.
There are a number of associated extracolonic manifestations which include congenital hypertrophy of the retinal pigment epithelium (CHRPE) Family N were found to be compound heterozygotes for Y165C and G382D
and the unaffected family members were either heterozygous for one of these variants or normal, suggesting transmission as an autosomal recessive trait.
Consistent with this, no somatic mutations in MYH were identified upon comprehensive analysis of the eleven MYH-deficient colorectal tumours (12) .
In an attempt to identify further cases, Jones et al. (Table 1 ). Nine were specified as having over 100 adenomas (one had over 400), eleven had 10-100 adenomas, and in five, the adenomas were "multiple, too many to count", "numerous" or "throughout the colon". 
The spectrum of MYH mutations and diagnostic issues
To-date, six truncating (252delG, Y90X, Q324X, 1103delC, E466X and 1419delC), four missense (W117R, Y165C, V232F and G382D), one in-frame insertion (137insIW) and two putative splice site mutations (347-1G→A and 891+3A→C) have been reported in MYH in patients with colorectal polyposis 
Concluding remarks
Although MYH polyposis appears to be transmitted as an autosomal recessive trait, the risk of colorectal adenoma and carcinoma in heterozygotes has not been determined. Neither is it clear whether inherited mutations in other components of the 8-oxoG repair system, or other BER glycosylases, predispose to tumours in humans. Whatever the outcome of investigations to address these questions, the myth that inherited defects of BER lack phenotypic consequences has now been firmly dispelled. 
